Figure 1.

This figure shows relative levels of LP (A) and ROS (B) in the synaptosomes prepared from the brains of controls and REMSD rats which were treated with or without AR alpha2 agonist (CLN) and alpha1antagonist (PRZ). The treatment details have been described in the method (this was done to reconfirm our earlier findings on set conditions Das et al., 2008). Levels of both LP and ROS were significantly reduced after REMSD. While REMSD associated reduction in LP was prevented by both PRZ and CLN (A), reduction in ROS level was prevented by CLN, but not by PRZ. N = 5 for each set. *p < 0.05, **p < 0.01, ***p < 0.001 as compared to FMC. Abbreviations are as in the text.